Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia

Keiko Shimokata, Yoshiji Yamada, Takahisa Kondo, Sahoko Ichihara, Hideo Izawa, Kohzo Nagata, Toyoaki Murohara, Miyoshi Ohno, Mitsuhiro Yokota

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

A substantial proportion of individuals with coronary artery disease (CAD) has concomitant hypercholesterolemia. A large-scale association study was performed to identify separately genes that confer susceptibility to CAD in the absence or presence of nonfamilial hypercholesterolemia. The study population comprised 5248 unrelated Japanese individuals, including 3085 subjects with CAD (2350 men, 735 women) and 2163 controls (1329 men, 834 women). Among all study subjects, 2541 individuals (1688 men, 853 women) had nonfamilial hypercholesterolemia, and 2707 individuals (1991 men, 716 women) did not have this condition. The genotypes for 33 polymorphisms of 27 candidate genes were determined with a fluorescence- or colorimetry-based allele-specific DNA primer-probe assay system. Multivariate logistic regression analysis with adjustment for age, body mass index, and the prevalence of smoking, hypertension, diabetes mellitus, and hyperuricemia revealed that three polymorphisms [994G → T (Val279Phe) in the platelet-activating factor acetylhydrolase gene, 242C → T (His72Tyr) in the NADH/NADPH oxidase p22 phox gene, and 1100C → T in the apolipoprotein C-III gene] were significantly associated with CAD in men with hypercholesterolemia. Genotyping of these three polymorphisms may prove informative for prediction of the genetic risk for CAD in men with nonfamilial hypercholesterolemia.

Original languageEnglish
Pages (from-to)167-173
Number of pages7
JournalAtherosclerosis
Volume172
Issue number1
DOIs
Publication statusPublished - 01-01-2004
Externally publishedYes

Fingerprint

Hypercholesterolemia
Coronary Artery Disease
Genes
Apolipoprotein C-III
Colorimetry
Hyperuricemia
DNA Primers
NADPH Oxidase
Platelet Activating Factor
DNA Probes
Diabetes Mellitus
Body Mass Index
Fluorescence
Logistic Models
Smoking
Alleles
Genotype
Regression Analysis
Hypertension
Population

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Shimokata, Keiko ; Yamada, Yoshiji ; Kondo, Takahisa ; Ichihara, Sahoko ; Izawa, Hideo ; Nagata, Kohzo ; Murohara, Toyoaki ; Ohno, Miyoshi ; Yokota, Mitsuhiro. / Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. In: Atherosclerosis. 2004 ; Vol. 172, No. 1. pp. 167-173.
@article{7c3e44d3e8754ce7a3d159768e1c275b,
title = "Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia",
abstract = "A substantial proportion of individuals with coronary artery disease (CAD) has concomitant hypercholesterolemia. A large-scale association study was performed to identify separately genes that confer susceptibility to CAD in the absence or presence of nonfamilial hypercholesterolemia. The study population comprised 5248 unrelated Japanese individuals, including 3085 subjects with CAD (2350 men, 735 women) and 2163 controls (1329 men, 834 women). Among all study subjects, 2541 individuals (1688 men, 853 women) had nonfamilial hypercholesterolemia, and 2707 individuals (1991 men, 716 women) did not have this condition. The genotypes for 33 polymorphisms of 27 candidate genes were determined with a fluorescence- or colorimetry-based allele-specific DNA primer-probe assay system. Multivariate logistic regression analysis with adjustment for age, body mass index, and the prevalence of smoking, hypertension, diabetes mellitus, and hyperuricemia revealed that three polymorphisms [994G → T (Val279Phe) in the platelet-activating factor acetylhydrolase gene, 242C → T (His72Tyr) in the NADH/NADPH oxidase p22 phox gene, and 1100C → T in the apolipoprotein C-III gene] were significantly associated with CAD in men with hypercholesterolemia. Genotyping of these three polymorphisms may prove informative for prediction of the genetic risk for CAD in men with nonfamilial hypercholesterolemia.",
author = "Keiko Shimokata and Yoshiji Yamada and Takahisa Kondo and Sahoko Ichihara and Hideo Izawa and Kohzo Nagata and Toyoaki Murohara and Miyoshi Ohno and Mitsuhiro Yokota",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.atherosclerosis.2003.09.019",
language = "English",
volume = "172",
pages = "167--173",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. / Shimokata, Keiko; Yamada, Yoshiji; Kondo, Takahisa; Ichihara, Sahoko; Izawa, Hideo; Nagata, Kohzo; Murohara, Toyoaki; Ohno, Miyoshi; Yokota, Mitsuhiro.

In: Atherosclerosis, Vol. 172, No. 1, 01.01.2004, p. 167-173.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia

AU - Shimokata, Keiko

AU - Yamada, Yoshiji

AU - Kondo, Takahisa

AU - Ichihara, Sahoko

AU - Izawa, Hideo

AU - Nagata, Kohzo

AU - Murohara, Toyoaki

AU - Ohno, Miyoshi

AU - Yokota, Mitsuhiro

PY - 2004/1/1

Y1 - 2004/1/1

N2 - A substantial proportion of individuals with coronary artery disease (CAD) has concomitant hypercholesterolemia. A large-scale association study was performed to identify separately genes that confer susceptibility to CAD in the absence or presence of nonfamilial hypercholesterolemia. The study population comprised 5248 unrelated Japanese individuals, including 3085 subjects with CAD (2350 men, 735 women) and 2163 controls (1329 men, 834 women). Among all study subjects, 2541 individuals (1688 men, 853 women) had nonfamilial hypercholesterolemia, and 2707 individuals (1991 men, 716 women) did not have this condition. The genotypes for 33 polymorphisms of 27 candidate genes were determined with a fluorescence- or colorimetry-based allele-specific DNA primer-probe assay system. Multivariate logistic regression analysis with adjustment for age, body mass index, and the prevalence of smoking, hypertension, diabetes mellitus, and hyperuricemia revealed that three polymorphisms [994G → T (Val279Phe) in the platelet-activating factor acetylhydrolase gene, 242C → T (His72Tyr) in the NADH/NADPH oxidase p22 phox gene, and 1100C → T in the apolipoprotein C-III gene] were significantly associated with CAD in men with hypercholesterolemia. Genotyping of these three polymorphisms may prove informative for prediction of the genetic risk for CAD in men with nonfamilial hypercholesterolemia.

AB - A substantial proportion of individuals with coronary artery disease (CAD) has concomitant hypercholesterolemia. A large-scale association study was performed to identify separately genes that confer susceptibility to CAD in the absence or presence of nonfamilial hypercholesterolemia. The study population comprised 5248 unrelated Japanese individuals, including 3085 subjects with CAD (2350 men, 735 women) and 2163 controls (1329 men, 834 women). Among all study subjects, 2541 individuals (1688 men, 853 women) had nonfamilial hypercholesterolemia, and 2707 individuals (1991 men, 716 women) did not have this condition. The genotypes for 33 polymorphisms of 27 candidate genes were determined with a fluorescence- or colorimetry-based allele-specific DNA primer-probe assay system. Multivariate logistic regression analysis with adjustment for age, body mass index, and the prevalence of smoking, hypertension, diabetes mellitus, and hyperuricemia revealed that three polymorphisms [994G → T (Val279Phe) in the platelet-activating factor acetylhydrolase gene, 242C → T (His72Tyr) in the NADH/NADPH oxidase p22 phox gene, and 1100C → T in the apolipoprotein C-III gene] were significantly associated with CAD in men with hypercholesterolemia. Genotyping of these three polymorphisms may prove informative for prediction of the genetic risk for CAD in men with nonfamilial hypercholesterolemia.

UR - http://www.scopus.com/inward/record.url?scp=0346094369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346094369&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2003.09.019

DO - 10.1016/j.atherosclerosis.2003.09.019

M3 - Article

C2 - 14709372

AN - SCOPUS:0346094369

VL - 172

SP - 167

EP - 173

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -